Analyst firms · H.C. Wainwright · NVAX

H.C. Wainwright NVAX price target and rating history

Novavax Inc. (NVAX) · Health Care

H.C. Wainwright rates Novavax Inc. (NVAX) Buy with a $10 price target, as of its latest action on Aug 28, 2025. It has published 3 rating actions on NVAX since March 2022, including 0 upgrades and 0 downgrades.

Current rating
Buy
Price target
$10
Median target, all firms
Too few
Actions on NVAX
3

H.C. Wainwright price target on NVAX

$207$109$102023202420252026
H.C. Wainwright price target on NVAX, each point a stated target, March 2022 to August 2025.

Every H.C. Wainwright rating on NVAX

Questions about H.C. Wainwright and NVAX

What is H.C. Wainwright's price target for NVAX?
H.C. Wainwright's latest stated price target for Novavax Inc. (NVAX) is $10, from its action on Aug 28, 2025.
What is H.C. Wainwright's rating on NVAX?
H.C. Wainwright rates NVAX Buy, a bullish rating, as of Aug 28, 2025.
When did H.C. Wainwright last change its view on NVAX?
On Aug 28, 2025, H.C. Wainwright resumes coverage at Buy, price target $10.

More NVAX rating histories

All H.C. Wainwright ratingsNVAX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.